Ronald E Osman Inhibitor Therapeutics, Inc. (INTI) insider trading activity

INTI Quotes by TradingView

Ronald E Osman is Director of Inhibitor Therapeutics, Inc.. Currently has a direct ownership of 23.5 Million shares of INTI, which is worth approximately $1.41 Million. The most recent transaction as insider was on Aug 11, 2023, when has been sold 25,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.5M
0% 3M change
0% 12M change
Total Value Held $1.41 Million

RONALD E OSMAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 11 2023
BUY
Grant, award, or other acquisition
-
25,000 Added 0.11%
23,514,985 Common Stock
REO

Ronald E Osman

Director
Cape Girardeau, MO

Track Institutional and Insider Activities on INTI

Follow Inhibitor Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INTI shares.

Notify only if

Insider Trading

Get notified when an Inhibitor Therapeutics, Inc. insider buys or sells INTI shares.

Notify only if

News

Receive news related to Inhibitor Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on INTI